XML 18 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Operating Activities:              
Net income (loss) $ 1,297 $ (3,037) $ (3,629) $ (3,831) $ (6,656) $ (10,990)  
Adjustments to reconcile net income (loss) to net cash used in operating activities:              
Depreciation and amortization         2,815 1,054  
Provision on credit losses         (124) 0  
Common stock issued for services         0 301  
Change in fair value of contingent consideration liabilities         (4,269) 260  
Employee stock-based compensation         2,001 1,289  
Disposal of property and equipment         65 0  
Amortization of operating lease right of use asset         616 0  
Abandoned patent costs         75 0  
Stock Compensation expense for non-employees         0 264  
(Increase) decrease in:              
Accounts receivable         4,997 (10,463)  
Prepaid expenses and other current assets         39 479  
Inventory         (352) (1,149)  
Deposits         (44) 0  
Increase (decrease) in:              
Accounts payable         (1,691) 4,341  
Accrued expenses         219 1,390  
Operating lease liability         (605) 0  
Sales tax payable         23 59  
Deferred revenue         348 (603)  
Other long term liabilities         (509) 0  
Net cash used in operating activities         (3,052) (13,768)  
Investing Activities:              
Acquisition, net of cash acquired         (513) 0  
Purchase of property and equipment         (431) (787)  
Payment of Deferred Consideration         (2,714) 0  
Funding of patent costs         0 (94)  
Net cash used in investing activities         (3,658) (881)  
Financing Activities:              
Proceeds from sale of common stock under committed equity facility, net of offering costs         496 2,107  
Taxes paid related to net share settlement of equity awards         (164) 0  
Proceeds from warrant exercises         810 137  
Borrowings of note payable         76 209  
Payments of equity offering costs         0 (151)  
Proceeds from issuance of common stock, pursuant to public offering         0 25,424  
Net cash provided by financing activities         1,218 27,726  
Effect of exchange rate changes         (27) 0  
Net (decrease) increase in cash         (5,518) 13,077  
Cash at beginning of period   $ 10,393   $ 1,681 10,393 1,681 $ 1,681
Cash at end of period $ 4,874   $ 14,758   4,874 14,758 $ 10,393
Supplemental Disclosure of Cash Flow Information:              
Cash paid for interest         28 6  
Cash paid for taxes         0 13  
Supplemental Disclosure of Non-Cash Investing and Financing Activities:              
Fair value of common stock issued as consideration for business combination         387 7,051  
Purchase of property and equipment by incurring debt         0 209  
Purchase of property and equipment by incurring current liabilities         431 0  
Right-of-use assets obtained in exchange for lease liabilities         1,421 0  
Issuance of stock for Committed Equity Line         0 140  
Warrants issued for services to non-employee         0 1,609  
Shares issued for services to non-employee         $ 0 $ 95